Fibromyalgia
Fibromyalgia patients are frequently substituting prescription medications for CBD products
Findings published in the Journal of Pain, report that patients frequently acknowledge substituting CBD products for opioids, NSAIDS and other commonly prescribed medications.
Researchers with the University of Michigan Medical School surveyed 878 fibromyalgia patients who were currently using CBD.
Seventy-two percent of respondents reported deliberately substituting CBD products in place of other medications, specifically opioids, NSAIDS, benzodiazepines, and gabapentanoids.
More than half (53 percent) swapped CBD for opioids and 23 percent used it in place of benzodiazepines.
Among those who used CBD, the majority reported decreasing or stopping use of these pain medications all together.
The most common reasons for substitution were fewer side effects and better symptom management.
The authors noted: “Those who substituted reported larger improvements in health and pain than those who did not. Participants using CBD-cannabis reported significantly more substitutions than any other group and larger improvements in health, pain, memory, and sleep than other subgroups.”
Several other studies indicate that cannabinoids can provide relief to patients with fibromyalgia.
Data published in February reported that the long-term use of medical cannabis is linked to improvements in pain and other symptoms.
Another study, published in 2020, also reported that cannabis therapy was associated with reductions in the use of prescribed medicines, as well as improvements in sleep and pain.
A round-up of the latest science, regulation and developments across the UK and Europe — in your inbox every week.
A round-up of the latest science, regulation and developments across the UK and Europe — in your inbox every week.